The evaluation of drug safety in clinical trials is a critical element of the drug development process, ensuring that therapeutic benefits outweigh potential harms. Clinical trials, particularly in ...

Deepanshu Saini, Director of Program Management at IQVIA reflects on the interplay between safety and AI pharmacovigilance.

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of results from an integrated safety analysis of UKONIQ® (umbralisib), the Company’s ...

The study of traffic safety and driver behaviour analysis encompasses the multidisciplinary evaluation of how drivers interact with evolving road environments, incorporating both behavioural ...

No cure is available, so children and their families must strictly avoid peanuts in order to prevent reactions. Yet, even with careful avoidance, inadvertent exposures to peanut can occur. According ...

These findings underscore the mechanistic elegance of interleukin (IL)-13 inhibition and highlight potential advantages of flexible dosing, according to the study's lead author, Eric L. Simpson, MD, ...

One of the most common food allergies worldwide is peanut allergy, a potentially chronic and life-long condition in which the immune system identifies even small amounts of peanut as harmful. 1 In the ...

The Draft Guidance provides an extensive overview of sponsors’ safety reporting requirements. However, in addition to general IND safety reporting requirements, a major focus is updated ...

Boeing’s use of data to flag possible safety issues is expanding rapidly, allowing the manufacturer to flag not only fleet-wide risks but also challenges that individual customers may be having.

Bimekizumab's safety profile was evaluated using FAERS data, identifying 2780 reports and 70 significant safety signals. The study found 29 previously unreported adverse events, including cellulitis ...

A new analysis of global pharmacovigilance data indicates that while reports of psychiatric distress are common among users ...